167 related articles for article (PubMed ID: 17062660)
1. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
Bunn PA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
[No Abstract] [Full Text] [Related]
2. Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer.
Viswanathan A; Pillot G; Govindan R
Lung Cancer; 2005 Dec; 50(3):417-8. PubMed ID: 16129510
[No Abstract] [Full Text] [Related]
3. Targeted therapy for non-small cell lung cancer.
Jett JR; Carr LL
Am J Respir Crit Care Med; 2013 Oct; 188(8):907-12. PubMed ID: 23721055
[TBL] [Abstract][Full Text] [Related]
4. Management of non-small cell lung cancer: focus on erlotinib. Foreword.
Cappuzzo F
Drugs; 2012 Jun; 72 Suppl 1():1-2. PubMed ID: 22712791
[No Abstract] [Full Text] [Related]
5. Cancer drugs. Smart weapons prove tough to design.
Couzin J
Science; 2002 Oct; 298(5593):522-5. PubMed ID: 12386312
[No Abstract] [Full Text] [Related]
6. Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines.
de Marinis F; Rossi A; Di Maio M; Ricciardi S; Gridelli C;
Lung Cancer; 2011 Jul; 73(1):1-10. PubMed ID: 21440325
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer.
Qi WX; Shen Z; Yao Y
Cancer Chemother Pharmacol; 2012 Jan; 69(1):99-106. PubMed ID: 21607554
[TBL] [Abstract][Full Text] [Related]
8. Second-line treatment for non-small-cell lung cancer: one size does not fit all.
Caponi S; Vasile E; Ginocchi L; Tibaldi C; Borghi F; D'Incecco A; Lucchesi M; Caparello C; Andreuccetti M; Falcone A
Clin Lung Cancer; 2010 Sep; 11(5):320-7. PubMed ID: 20837457
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.
Des Guetz G; Uzzan B; Nicolas P; Valeyre D; Sebbane G; Morere JF
Crit Rev Oncol Hematol; 2012 Dec; 84(3):340-9. PubMed ID: 22534083
[TBL] [Abstract][Full Text] [Related]
10. New options for integrating antiangiogenic therapy and platinum-based first-line chemotherapy for advanced non-small-cell lung cancer.
Manegold C
Clin Lung Cancer; 2008; 9 Suppl 3():S100-8. PubMed ID: 19419923
[TBL] [Abstract][Full Text] [Related]
11. [Comparison between single-agent and platinum-doublet chemotherapy in elderly patients with non-small cell lung cancer].
Tamiya A; Naito T; Takahashi T; Endo M; Yamamoto N
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1897-901. PubMed ID: 20948252
[TBL] [Abstract][Full Text] [Related]
12. First-line erlotinib inferior to chemo in advanced lung cancer.
Oncology (Williston Park); 2012 Oct; 26(10):930-1. PubMed ID: 23176004
[No Abstract] [Full Text] [Related]
13. Second-line erlotinib for non-small-cell lung cancer.
Lorusso V; Cinieri S
Lancet Oncol; 2012 Apr; 13(4):e141-2; author reply e142. PubMed ID: 22469123
[No Abstract] [Full Text] [Related]
14. Beyond first-line NSCLC therapy: chemotherapy or erlotinib?
Paz-Ares L
Lancet Oncol; 2012 Mar; 13(3):225-7. PubMed ID: 22277836
[No Abstract] [Full Text] [Related]
15. Non-small-cell lung cancer patients unsuitable for first-line chemotherapy: a new category of patients for clinical studies?
Soto Parra HJ; Latteri F; Cavina R; De Vincenzo F; Zucali PA; Campagnoli E; Santoro A
J Am Geriatr Soc; 2005 Jun; 53(6):1078-80. PubMed ID: 15935045
[No Abstract] [Full Text] [Related]
16. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
Bergman B
Lakartidningen; 1997 Apr; 94(18):1702, 1707-10. PubMed ID: 9182178
[No Abstract] [Full Text] [Related]
17. Recent advances in chemotherapy for lung cancer.
Lilenbaum RC
Curr Opin Pulm Med; 1996 Jul; 2(4):285-9. PubMed ID: 9363153
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
[TBL] [Abstract][Full Text] [Related]
19. [Established new drugs in the chemotherapy of non-small-cell lung carcinoma (NSCLC)].
Serke M
Dtsch Med Wochenschr; 2000 Feb; 125(8):225. PubMed ID: 10723459
[No Abstract] [Full Text] [Related]
20. [Chemotherapy in cancer of the lung].
Gütz S
MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
